BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 1998;227:424-432. [PMID: 9527066 DOI: 10.1097/00000658-199803000-00015] [Cited by in Crossref: 176] [Cited by in F6Publishing: 167] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Tang ZY. Hepatocellular carcinoma--cause, treatment and metastasis. World J Gastroenterol. 2001;7:445-454. [PMID: 11819809 DOI: 10.3748/wjg.v7.i4.445] [Cited by in CrossRef: 275] [Cited by in F6Publishing: 258] [Article Influence: 14.5] [Reference Citation Analysis]
2 Wong LL, Tanaka K, Lau L, Komura S. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant. 2004;18:227-234. [PMID: 15142041 DOI: 10.1111/j.1399-0012.2004.00164.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
3 Befeler A, Di Bisceglie AM. Treatment of hepatocellular carcinoma. Viruses and Liver Cancer. Elsevier; 2002. pp. 161-72. [DOI: 10.1016/s0168-7069(02)06074-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Nissen NN, Cavazzoni E, Tran TT, Poordad FP. Emerging Role of Transplantation for Primary Liver Cancers: . The Cancer Journal 2004;10:88-96. [DOI: 10.1097/00130404-200403000-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
5 Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, Starzl TE. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389-394. [PMID: 11030244 DOI: 10.1016/s1072-7515(00)00688-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
6 Shirabe K, Kajiyama K, Harimoto N, Masumoto H, Fukuya T, Ooya M, Maehara Y. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol. 2009;15:2632-2637. [PMID: 19496194 DOI: 10.3748/wjg.15.2632] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
7 Chen XH, Zhang BH, Xin Y, Ren ZG, Fan J, Qiu SJ, Zhou J. Risk factors for residual tumor after resection of hepatocellular carcinoma. World J Gastroenterol. 2011;17:1889-1894. [PMID: 21528064 DOI: 10.3748/wjg.v17.i14.1889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Seymour K, Charnley RM, Rose JD, Baudouin CJ, Manas D. Preoperative portal vein embolisation for primary and metastatic liver tumours: volume effects, efficacy, complications and short-term outcome. HPB (Oxford) 2002;4:21-8. [PMID: 18333148 DOI: 10.1080/136518202753598690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Wong LL, Tsai N, Limm W, Wong L. Liver transplant for hepatocellular cancer: a treatment for the select few. Clin Transplant 2004;18:205-10. [PMID: 15016137 DOI: 10.1046/j.1399-0012.2003.00157.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
10 Lei JY, Yan LN, Wang WT. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol. 2013;19:4400-4408. [PMID: 23885153 DOI: 10.3748/wjg.v19.i27.4400] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
11 Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2005;3:75-84. [PMID: 15645408 DOI: 10.1016/s1542-3565(04)00443-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
12 Kawamura Y, Ikeda K, Hirakawa M, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma. Hepatol Res. 2010;40:1006-1014. [PMID: 20887336 DOI: 10.1111/j.1872-034x.2010.00703.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
13 Kawamura Y, Ikeda K, Shindoh J, Kobayashi Y, Kasuya K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Hashimoto M, Kumada H. No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection: No-touch ablation for HCC. Hepatol Res 2019;49:164-76. [DOI: 10.1111/hepr.13254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
14 Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609-1619. [PMID: 12016426 DOI: 10.1053/gast.2002.33411] [Cited by in Crossref: 374] [Cited by in F6Publishing: 347] [Article Influence: 19.7] [Reference Citation Analysis]
15 Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, Balan V. Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver Transplantation. Am J Transplant 2006;6:1957-62. [DOI: 10.1111/j.1600-6143.2006.01411.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
16 Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, Chang FY, Lee SD. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol. 2003;98:2293-2298. [PMID: 14572582 DOI: 10.1111/j.1572-0241.2003.07688.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
17 Del Gaudio M, Ercolani G, Ravaioli M, Cescon M, Lauro A, Vivarelli M, Zanello M, Cucchetti A, Vetrone G, Tuci F. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant. 2008;8:1177-1185. [PMID: 18444925 DOI: 10.1111/j.1600-6143.2008.02229.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 113] [Article Influence: 8.8] [Reference Citation Analysis]
18 Shah SA, Tan JC, McGilvray ID, Cattral MS, Levy GA, Greig PD, Grant DR. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg 2007;11:464-71. [PMID: 17436131 DOI: 10.1007/s11605-006-0033-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
19 Davis CR. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010;17:87-99. [PMID: 20404792 DOI: 10.1177/107327481001700204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
20 Nitta H, Allard MA, Sebagh M, Ciacio O, Pittau G, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Guettier C, Lewin M, Samuel D, Baba H, Adam R. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma. Ann Surg Oncol 2019;26:2568-76. [PMID: 31054040 DOI: 10.1245/s10434-019-07365-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
21 Shao Z, Lopez R, Shen B, Yang GS. Orthotopic liver transplantation as a rescue operation for recurrent hepatocellular carcinoma after partial hepatectomy. World J Gastroenterol 2008;14:4370-6. [PMID: 18666328 DOI: 10.3748/wjg.14.4370] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
22 Sotiropoulos GC, Malag?? M, Molmenti EP, Nadalin S, Radtke A, Brokalaki EI, Lang H, Frilling A, Baba HA, Neuh??user M, Broelsch CE. Liver Transplantation and Incidentally Found Hepatocellular Carcinoma in Liver Explants: Need for a New Definition?: . Transplantation 2006;81:531-5. [DOI: 10.1097/01.tp.0000198739.42548.3e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
23 McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005;17:497-503. [PMID: 15827439 DOI: 10.1097/00042737-200505000-00005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
24 Figueras J, Ramos E, Ibáñez L, Valls C, Serrano T, Rafecas A, Casanovas T, Fabregat J, Xiol X, Torras J. [Surgical treatment of hepatocellular carcinoma. Long term results]. Med Clin (Barc). 2002;118:410-414. [PMID: 11943103 DOI: 10.1016/S0025-7753(02)72404-4] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
25 Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, Sommacale D, Dondero F, Lesurtel M, Sauvanet A. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;238:885-892; discussion 892-893. [PMID: 14631225 DOI: 10.1097/01.sla.0000098621.74851.65] [Cited by in Crossref: 313] [Cited by in F6Publishing: 271] [Article Influence: 17.4] [Reference Citation Analysis]
26 Xu X, Liu C, Qu K, Song Y, Zhang P, Zhang Y. Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis. Hepatobiliary & Pancreatic Diseases International 2014;13:234-41. [DOI: 10.1016/s1499-3872(14)60037-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
27 Prince MI, Hudson M. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad Med J 2002;78:135-41. [PMID: 11884694 DOI: 10.1136/pmj.78.917.135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
28 Delis SG, Bakoyiannis A, Tassopoulos N, Athanassiou K, Kelekis D, Madariaga J, Dervenis C. Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. Surg Oncol. 2010;19:200-207. [PMID: 19500972 DOI: 10.1016/j.suronc.2009.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
29 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg. 2002;235:373-382. [PMID: 11882759 DOI: 10.1097/00000658-200203000-00009] [Cited by in Crossref: 596] [Cited by in F6Publishing: 563] [Article Influence: 31.4] [Reference Citation Analysis]
30 Zhang Q, Deng YL, Liu C, Huang LH, Shang L, Chen XG, Wang LT, Du JZ, Wang Y, Wang PX, Zhang H, Shen ZY. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol 2016;22:9571-85. [PMID: 27920478 DOI: 10.3748/wjg.v22.i43.9571] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
31 Shrimal A, Prasanth M, Kulkarni AV. Interventional radiological treatment of hepatocellular carcinoma: an update. Indian J Surg 2012;74:91-9. [PMID: 23372313 DOI: 10.1007/s12262-011-0377-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
32 Williams R, White J, Croce M, Dilawari R. Surgical Options in the Treatment of Hepatocellular Carcinoma. The American Surgeon 2007;73:658-62. [DOI: 10.1177/000313480707300704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S, Maehara Y. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007;95:235-240. [PMID: 17323337 DOI: 10.1002/jso.20655] [Cited by in Crossref: 121] [Cited by in F6Publishing: 123] [Article Influence: 8.6] [Reference Citation Analysis]
34 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg. 2007;245:51-58. [PMID: 17197965 DOI: 10.1097/01.sla.] [Reference Citation Analysis]
35 Uchida H, Iwashita Y, Sasaki A, Shibata K, Matsumoto T, Ohta M, Kitano S. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 2006;21:161-168. [PMID: 16706828 DOI: 10.1111/j.1440-1746.2005.04157.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
36 Shirabe K, Kajiyama K, Abe T, Sakamoto S, Fukuya T, Akazawa K, Morita K, Maehara Y. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio. J Gastroenterol Hepatol. 2009;24:1431-1436. [PMID: 19486447 DOI: 10.1111/j.1440-1746.2009.05847.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
37 Merchant N, David CS, Cunningham SC. Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection. Int J Hepatol 2011;2011:142085. [PMID: 21994848 DOI: 10.4061/2011/142085] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
38 Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B, Moutardier V, Farges O, Valla D. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol. 2001;35:254-258. [PMID: 11580148 DOI: 10.1016/s0168-8278(01)00108-8] [Cited by in Crossref: 180] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
39 Ziparo V, Balducci G, Lucandri G, Mercantini P, Di Giacomo G, Fernandes E. Indications and results of resection for hepatocellular carcinoma. Eur J Surg Oncol. 2002;28:723-728. [PMID: 12431469 DOI: 10.1053/ejso.2002.1299] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
40 Morioka D, Tanaka K, Matsuo K, Takeda K, Ueda M, Sugita M, Nagano Y, Endo I, Sekido H, Togo S, Shimada H. Applicability of the Milan Criteria for Determining Liver Transplantation as a First-Line Treatment for Hepatocellular Carcinoma. Ann Surg Oncol 2006;13:1500-10. [DOI: 10.1245/s10434-006-9204-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
41 Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000;88:538-43. [DOI: 10.1002/(sici)1097-0142(20000201)88:3<538::aid-cncr7>3.0.co;2-h] [Cited by in Crossref: 148] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
42 Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2010;102:462-468. [PMID: 20872949 DOI: 10.1002/jso.21631] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 8.3] [Reference Citation Analysis]
43 Wan YL, Zheng SS, Zhao ZC, Li MW, Jia CK, Zhang H. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity. World J Gastroenterol 2004;10:195-9. [PMID: 14716821 DOI: 10.3748/wjg.v10.i2.195] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
44 Wu CC, Ho WL, Chen JT, Tang CS, Yeh DC, Liu TJ, P'eng FK. Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure. J Am Coll Surg 1999;188:508-15. [PMID: 10235579 DOI: 10.1016/s1072-7515(99)00026-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
45 Kaibori M, Ishizaki M, Matsui K, Kwon AH. Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy. Am J Surg. 2012;204:300-307. [PMID: 22591698 DOI: 10.1016/j.amjsurg.2011.11.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
46 Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl. 2004;10:36-41. [PMID: 14755775 DOI: 10.1002/lt.20012] [Cited by in Crossref: 196] [Cited by in F6Publishing: 175] [Article Influence: 11.5] [Reference Citation Analysis]
47 Agthoven M, Ineveld BM, Metselaar H, Man RA, Tilanus H, Ijzermans JNM. A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure. Transplant Int 2001;14:87-94. [DOI: 10.1111/j.1432-2277.2001.tb00019.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
48 Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy? Ann Surg. 2003;238:508-18; discussion 518-9. [PMID: 14530722 DOI: 10.1097/01.sla.0000090449.87109.44] [Cited by in Crossref: 66] [Cited by in F6Publishing: 125] [Article Influence: 3.7] [Reference Citation Analysis]
49 He S, Fan X, Ma H, Xiaerfuhazi H, Rehato A, Feng J, Shi X, He F. Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy. Oncol Lett 2019;18:1824-30. [PMID: 31423250 DOI: 10.3892/ol.2019.10517] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Kawamura Y, Ikeda K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y. Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules. Hepatol Res. 2017;47:338-346. [PMID: 27249401 DOI: 10.1111/hepr.12754] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Sorrentino P, Tarantino L, D’Angelo S, Terracciano L, Ferbo U, Bracigliano A, Panico L, De Chiara G, Lepore M, De Stefano N. Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis. J Gastroenterol Hepatol. 2011;26:669-677. [PMID: 21054520 DOI: 10.1111/j.1440-1746.2010.06564.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
52 Molmenti EP, Klintmalm GB. Cancer and liver transplantation. Transplantation Reviews 2000;14:183-98. [DOI: 10.1053/trre.2000.16513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
53 Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology. 2005;128:1752-1764. [PMID: 15887162 DOI: 10.1053/j.gastro.2005.03.033] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 5.8] [Reference Citation Analysis]
54 Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, Nakajima Y. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 2002;89:57-62. [PMID: 11851664 DOI: 10.1046/j.0007-1323.2001.01969.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.6] [Reference Citation Analysis]
55 J. Cheng S, Pratt DS, Freeman RB, Kaplan MM, Wong JB. LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1: . Transplantation 2001;72:861-8. [DOI: 10.1097/00007890-200109150-00021] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
56 Kawamura Y, Ikeda K, Seko Y, Hosaka T, Kobayashi M, Saitoh S, Kumada H. Heterogeneous Type 4 Enhancement of Hepatocellular Carcinoma on Dynamic CT Is Associated With Tumor Recurrence After Radiofrequency Ablation. American Journal of Roentgenology 2011;197:W665-73. [DOI: 10.2214/ajr.11.6843] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
57 Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-391. [PMID: 10973388 DOI: 10.1097/00000658-200009000-00010] [Cited by in Crossref: 542] [Cited by in F6Publishing: 457] [Article Influence: 25.8] [Reference Citation Analysis]
58 Wong LL. Current status of liver transplantation for hepatocellular cancer. Am J Surg. 2002;183:309-316. [PMID: 11943133 DOI: 10.1016/s0002-9610(02)00785-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
59 Kaibori M, Matsui Y, Kwon A, Tokoro T, Kamiyama Y. Prognosis of Hepatocellular Carcinoma after Hepatectomy in Patients with Renal Dysfunction. World J Surg 2005;29:375-81. [DOI: 10.1007/s00268-004-7515-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
60 Ryu T, Takami Y, Wada Y, Tateishi M, Hara T, Yoshitomi M, Momosaki S, Yasumori K, Saitsu H, Okuda K. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. J Gastrointest Surg 2019;23:779-87. [PMID: 30788712 DOI: 10.1007/s11605-019-04134-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
61 Morisco F, Stigliano R, Godfrey A, Leandro G, Patch D, Davidson B, Rolles K, Dhillon A, Dhillon AP, Quaglia A. Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients. Dig Dis Sci. 2008;53:1131-1137. [PMID: 17934816 DOI: 10.1007/s10620-007-9986-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
62 Guimaraes M, Uflacker R. Locoregional therapy for hepatocellular carcinoma. Clin Liver Dis 2011;15:395-421, vii-x. [PMID: 21689621 DOI: 10.1016/j.cld.2011.03.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
63 Takada Y, Ueda M, Ito T, Sakamoto S, Haga H, Maetani Y, Ogawa K, Kasahara M, Oike F, Egawa H. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl. 2006;12:912-919. [PMID: 16489583 DOI: 10.1002/lt.20642] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
64 Vauthey JN, Rousseau DL Jr. Liver imaging. A surgeon's perspective. Clin Liver Dis 2002;6:271-95. [PMID: 11933593 DOI: 10.1016/s1089-3261(03)00076-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Bruix J, Sherman M;  Practice Guidelines Committee;  American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. [PMID: 16250051 DOI: 10.1002/hep.20933] [Cited by in Crossref: 4104] [Cited by in F6Publishing: 3733] [Article Influence: 256.5] [Reference Citation Analysis]
66 Sotiropoulos GC, Malagó M, Molmenti EP, Lösch C, Lang H, Frilling A, Broelsch CE, Neuhäuser M. Hilar lymph nodes sampling at the time of liver transplantation for hepatocellular carcinoma: to do or not to do? Meta-analysis to determine the impact of hilar lymph nodes metastases on tumor recurrence and survival in patients with hepatocellular carcinoma undergoing liver transplantation. Transpl Int 2007;20:141-6. [PMID: 17239022 DOI: 10.1111/j.1432-2277.2006.00412.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
67 Gassmann P, Spieker T, Haier J, Schmidt F, Mardin WA, Senninger N. Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg 2010;34:2442-51. [PMID: 20544346 DOI: 10.1007/s00268-010-0655-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
68 Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011;17 Suppl 2:S44-S57. [PMID: 21695773 DOI: 10.1002/lt.22365] [Cited by in Crossref: 320] [Cited by in F6Publishing: 279] [Article Influence: 35.6] [Reference Citation Analysis]
69 Li HY, Wei YG, Yan LN, Li B. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis. World J Gastroenterol. 2012;18:2415-2422. [PMID: 22654435 DOI: 10.3748/wjg.v18.i19.2415.] [Reference Citation Analysis]
70 Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375-1382. [PMID: 18324443 DOI: 10.1245/s10434-008-9846-9] [Cited by in Crossref: 249] [Cited by in F6Publishing: 233] [Article Influence: 19.2] [Reference Citation Analysis]
71 Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery. 2006;139:385-394. [PMID: 16546504 DOI: 10.1016/j.surg.2005.08.035] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
72 Imura S, Teraoku H, Yoshikawa M, Ishikawa D, Yamada S, Saito Y, Iwahashi S, Ikemoto T, Morine Y, Shimada M. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria. Int J Clin Oncol 2018;23:98-103. [PMID: 28875240 DOI: 10.1007/s10147-017-1189-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
73 Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl. 2004;10:1478-1486. [PMID: 15558585 DOI: 10.1002/lt.20303] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
74 Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, Yamasaki S, Starzl TE. Should hepatomas be treated with hepatic resection or transplantation? Cancer. 1999;86:1151-1158. [PMID: 10506698 DOI: 10.1002/(sici)1097-0142(19991001)86:7<1151::aid-cncr8>3.0.co;2-v] [Reference Citation Analysis]
75 Ofosu A, Gurakar A. Current Concepts in Hepatocellular Carcinoma and Liver Transplantation: A Review and 2014 Update. Euroasian J Hepatogastroenterol 2015;5:19-25. [PMID: 29201680 DOI: 10.5005/jp-journals-10018-1123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 Sotiropoulos GC, Drühe N, Sgourakis G, Molmenti EP, Beckebaum S, Baba HA, Antoch G, Hilgard P, Radtke A, Saner FH, Nadalin S, Paul A, Malagó M, Broelsch CE, Lang H. Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach? Dig Dis Sci 2009;54:2264-73. [DOI: 10.1007/s10620-008-0604-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
77 Proneth A, Zeman F, Schlitt HJ, Schnitzbauer AA. Is Resection or Transplantation the ideal Treatment in Patients with Hepatocellular Carcinoma in Cirrhosis if Both Are Possible? A Systematic Review and Metaanalysis. Ann Surg Oncol 2014;21:3096-107. [DOI: 10.1245/s10434-014-3808-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 6.1] [Reference Citation Analysis]
78 Delis SG, Bakoyiannis A, Tassopoulos N, Athanassiou K, Kechagias A, Kelekis D, Madariaga J, Dervenis C. Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB (Oxford) 2009;11:551-8. [PMID: 20495706 DOI: 10.1111/j.1477-2574.2009.00084.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
79 Yang J, Zhu S, Yong J, Xia L, Qian X, Yang J, Hu X, Li Y, Wang C, Peng W, Zhang L, Deng M, Pan W. A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation. Front Oncol 2021;11:616976. [PMID: 33747929 DOI: 10.3389/fonc.2021.616976] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Huo T, Wu J, Lui W, Huang Y, Lee P, Chiang J, Chang F, Lee S. Differential Mechanism and Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma Undergoing Surgical and Nonsurgical Treatment. Am J Gastroenterology 2004;99:1479-87. [DOI: 10.1111/j.1572-0241.2004.30024.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
81 De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, Cardillo M, Forti D. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. Journal of the American College of Surgeons 2003;196:887-97. [DOI: 10.1016/s1072-7515(03)00140-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
82 Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol. 2003;21:4329-4335. [PMID: 14581446 DOI: 10.1200/jco.2003.11.137] [Cited by in Crossref: 181] [Cited by in F6Publishing: 44] [Article Influence: 10.1] [Reference Citation Analysis]
83 Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci 2006;51:1070-8. [PMID: 16865573 DOI: 10.1007/s10620-006-8011-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
84 Moon D, Lee S, Hwang S. Liver Transplantation for Hepatocellular Carcinoma: Single Nodule with Child-Pugh Class A Sized Less than 3 cm. Dig Dis 2007;25:320-8. [DOI: 10.1159/000106912] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
85 Tsao JI, DeSanctis J, Rossi RL, Oberfield RA. Hepatic malignancies. Surg Clin North Am. 2000;80:603-632. [PMID: 10836009 DOI: 10.1016/s0039-6109(05)70203-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
86 Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007;141:330-339. [PMID: 17349844 DOI: 10.1016/j.surg.2006.06.028] [Cited by in Crossref: 258] [Cited by in F6Publishing: 240] [Article Influence: 17.2] [Reference Citation Analysis]
87 Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol. 2010;101:47-53. [PMID: 19798686 DOI: 10.1002/jso.21415] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 8.4] [Reference Citation Analysis]
88 Bartlett A, Heaton N. Hepatocellular carcinoma: defining the place of surgery in an era of organ shortage. World J Gastroenterol. 2008;14:4445-4453. [PMID: 18680222 DOI: 10.3748/wjg.14.4445] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
89 Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study: α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study. Hepatology 2002;35:853-60. [DOI: 10.1053/jhep.2002.32100] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 3.7] [Reference Citation Analysis]
90 Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer. 2000;88:538-543. [PMID: 10649244 DOI: 10.1002/(SICI)1097-0142(20000201)88:3%3C538::AID-CNCR7%3E3.0.CO;2-H] [Reference Citation Analysis]
91 Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol. 2000;7:764-770. [PMID: 11129425 DOI: 10.1007/s10434-000-0764-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 4.2] [Reference Citation Analysis]
92 Zhang Q, Chen X, Zang Y, Zhang L, Chen H, Wang L, Niu Y, Ren X, Shen Z, Shang L. The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis. PLoS One. 2012;7:e50919. [PMID: 23236406 DOI: 10.1371/journal.pone.0050919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
93 Portolani N, Baiocchi GL, Molfino S, Benetti A, Gheza F, Giulini SM. Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma. World J Surg 2014;38:1769-76. [PMID: 24378549 DOI: 10.1007/s00268-013-2426-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
94 Yoo PS, Enestvedt CK, Kulkarni S. Anatomic Considerations in the Surgical Resection of Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2013;47:S11-5. [DOI: 10.1097/mcg.0b013e318280ce5f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
95 Rahman A, Assifi MM, Pedroso FE, Maley WR, Sola JE, Lavu H, Winter JM, Yeo CJ, Koniaris LG. Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis. J Gastrointest Surg. 2012;16:1897-1909. [PMID: 22836922 DOI: 10.1007/s11605-012-1973-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
96 Li HY, Wei YG, Yan LN, Li B. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis. World J Gastroenterol. 2012;18:2415-2422. [PMID: 22654435 DOI: 10.3748/wjg.v18.i19.2415] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
97 Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg. 2003;7:1082-1088. [PMID: 14675719 DOI: 10.1097/00000658-200205000-00015] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 8.1] [Reference Citation Analysis]
98 Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, Weber JC, Audet M, Doffoël M, Wolf P. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl. 2003;9:513-520. [PMID: 12740796 DOI: 10.1053/jlts.2003.50070] [Cited by in Crossref: 126] [Cited by in F6Publishing: 120] [Article Influence: 7.0] [Reference Citation Analysis]
99 Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS. Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg. 2006;10:413-416. [PMID: 16504888 DOI: 10.1016/j.gassur.2005.06.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
100 Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery. 2002;131:S153-S158. [PMID: 11821803 DOI: 10.1067/msy.2002.119497] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
101 Huo T, Wu J, Lui W, Lee R, Loong C, Huang Y, Tsay S, Chang F, Lee S. Reliability of contemporary radiology to measure tumour size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications. Scandinavian Journal of Gastroenterology 2009;39:46-52. [DOI: 10.1080/00365520310007242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
102 Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghiti J, Curley SA. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002;6:224-232; discussion 232. [PMID: 11992808 DOI: 10.1016/s1091-255x(01)00015-4] [Cited by in Crossref: 177] [Cited by in F6Publishing: 57] [Article Influence: 9.3] [Reference Citation Analysis]
103 Jaeck D, Bachellier P, Oussoultzoglou E, Weber J, Wolf P. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: An overview. Liver Transpl 2004;10:S58-63. [DOI: 10.1002/lt.20041] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
104 Nitta H, Adam R. ASO Author Reflections: Location of Microvascular Invasion in Hepatocellular Carcinoma-Intratumoral or Extratumoral Microvascular Invasion. Ann Surg Oncol 2020;27:723-4. [PMID: 32779047 DOI: 10.1245/s10434-019-07874-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Hertl M, Cosimi AB. Liver transplantation for malignancy. Oncologist. 2005;10:269-281. [PMID: 15821247 DOI: 10.1634/theoncologist.10-4-269] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 5.3] [Reference Citation Analysis]
106 Kim H, Park MS, Choi JY, Park YN, Kim MJ, Kim KS, Choi JS, Han KH, Kim E, Kim KW. Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 2009;19:1744-51. [PMID: 19247666 DOI: 10.1007/s00330-009-1331-8] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 8.1] [Reference Citation Analysis]
107 De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim A, Bondinara G, Cardillo M, Scalamogna M, Forti D. Treatment of HCC: the role of liver resection in the era of transplantation. Transplantation Proceedings 2001;33:1453-6. [DOI: 10.1016/s0041-1345(00)02550-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
108 Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl. 2002;8:736-748. [PMID: 12200772 DOI: 10.1053/jlts.2002.34879] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 5.7] [Reference Citation Analysis]
109 De Carlis L, Di Sandro S, Giacomoni A, Mangoni I, Lauterio A, Mihaylov P, Cusumano C, Rampoldi A. Liver Transplantation for Hepatocellular Carcinoma Recurrence After Liver Resection: Why Deny This Chance of Cure? Journal of Clinical Gastroenterology 2013;47:352-8. [DOI: 10.1097/mcg.0b013e31826e6caf] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
110 Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, Yamasaki S, Starzl TE. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999;86:1151-8. [DOI: 10.1002/(sici)1097-0142(19991001)86:7<1151::aid-cncr8>3.0.co;2-v] [Cited by in Crossref: 100] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
111 Chen J, Xu X, Ling Q, Wu J, Zheng S. Role of Pittsburgh Modified TNM Criteria in prognosis prediction of liver transplantation for hepatocellular carcinoma: . Chinese Medical Journal 2007;120:2200-3. [DOI: 10.1097/00029330-200712020-00008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
112 Kawamura Y, Ikeda K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas. Hepatol Res 2017;47:1008-20. [PMID: 27862748 DOI: 10.1111/hepr.12838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
113 Salmi A, Turrini R, Lanzani G, Savio A, Anglani L. Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis. Int J Med Sci 2008;5:327-32. [PMID: 18974861 DOI: 10.7150/ijms.5.327] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
114 She WH, Chan ACY, Cheung TT, Lo CM, Chok KSH. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. World J Hepatol. 2018;10:308-318. [PMID: 29527266 DOI: 10.4254/wjh.v10.i2.308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
115 Poon RTP. Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection? Ann Surg Oncol 2007;14:541-7. [DOI: 10.1245/s10434-006-9156-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
116 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Reference Citation Analysis]
117 Hoshida Y. Difficulties in Conducting Controlled Trials in Radical Therapies for Nonadvanced Hepatocellular Carcinoma. Hepatology 2000;32:877-81. [DOI: 10.1053/jhep.2000.17918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
118 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 684] [Cited by in F6Publishing: 656] [Article Influence: 62.2] [Reference Citation Analysis]
119 Murali AR, Patil S, Phillips KT, Voigt MD. Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. Transplantation 2017;101:e249-57. [DOI: 10.1097/tp.0000000000001730] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
120 Sala M, Fuster J, Llovet JM, Navasa M, Solé M, Varela M, Pons F, Rimola A, García-Valdecasas JC, Brú C. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl. 2004;10:1294-1300. [PMID: 15376311 DOI: 10.1002/lt.20202] [Cited by in Crossref: 223] [Cited by in F6Publishing: 198] [Article Influence: 13.9] [Reference Citation Analysis]
121 Bellavance EC, Lumpkins KM, Mentha G, Marques HP, Capussotti L, Pulitano C, Majno P, Mira P, Rubbia-brandt L, Ferrero A, Aldrighetti L, Cunningham S, Russolillo N, Philosophe B, Barroso E, Pawlik TM. Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation? J Gastrointest Surg 2008;12:1699-708. [DOI: 10.1007/s11605-008-0652-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
122 Santoyo J, Suárez M, Fernández J, Jiménez M, Ramírez C, Pérez Daga A, Bondia J, de la Fuente A. Tratamiento quirúrgico del hepatocarcinoma en el paciente cirrótico: ¿resección o trasplante? Cirugía Española 2001;70:42-8. [DOI: 10.1016/s0009-739x(01)71839-8] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
123 Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24. [PMID: 10862190 DOI: 10.1097/00000658-200007000-00003] [Cited by in Crossref: 551] [Cited by in F6Publishing: 520] [Article Influence: 26.2] [Reference Citation Analysis]
124 Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10:S39-S45. [PMID: 14762838 DOI: 10.1002/lt.20040] [Cited by in Crossref: 146] [Cited by in F6Publishing: 146] [Article Influence: 8.6] [Reference Citation Analysis]
125 Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, Yamasaki S, Starzl TE. Should hepatomas be treated with hepatic resection or transplantation? Cancer. 1999;86:1151-1158. [PMID: 10506698 DOI: 10.1002/(sici)1097-0142(19991001)86] [Reference Citation Analysis]
126 Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis. Hepatology. 2000;31:899-906. [PMID: 10733546 DOI: 10.1053/he.2000.5763] [Cited by in Crossref: 234] [Cited by in F6Publishing: 219] [Article Influence: 11.1] [Reference Citation Analysis]
127 Sudan D, Sudan R, Schafer D, Langnas A. Without victory there is no survival: Transarterial lipiodol chemoembolization and hepatocellular carcinoma. Hepatology 1998;28:270-1. [DOI: 10.1002/hep.510280137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
128 Robinson MK, Weiner LM, Adams GP. Improving mono-clonal antibodies for cancer therapy. Drug Development Res. 2004;61:172-187. [PMID: 11819809 DOI: 10.1002/ddr.10345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
129 Cunningham SC, Tsai S, Marques HP, Mira P, Cameron A, Barroso E, Philosophe B, Pawlik TM. Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis. Ann Surg Oncol 2009;16:1820-31. [DOI: 10.1245/s10434-009-0364-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
130 Tang ZY. Hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15 Suppl:G1-G7. [PMID: 11100985 DOI: 10.1046/j.1440-1746.2000.02257.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
131 Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, Chau GY, Tsay SH, Chang FY, Lee SD. Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol. 2003;15:1203-1208. [PMID: 14560154 DOI: 10.1097/00042737-200311000-00009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
132 Onaca N, Klintmalm GB. Liver transplantation for hepatocellular carcinoma: the Baylor experience. J Hepatobiliary Pancreat Sci 2010;17:559-66. [PMID: 19727543 DOI: 10.1007/s00534-009-0163-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
133 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007;245:51-8. [PMID: 17197965 DOI: 10.1097/01.sla.0000225255.01668.65] [Cited by in Crossref: 127] [Cited by in F6Publishing: 122] [Article Influence: 9.1] [Reference Citation Analysis]
134 Schoenberg MB, Bucher JN, Vater A, Bazhin AV, Hao J, Guba MO, Angele MK, Werner J, Rentsch M. Resection or Transplant in Early Hepatocellular Carcinoma. Dtsch Arztebl Int 2017;114:519-26. [PMID: 28835324 DOI: 10.3238/arztebl.2017.0519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
135 Marsh JW, Geller DA, Finkelstein SD, Donaldson JB, Dvorchik I. Role of liver transplantation for hepatobiliary malignant disorders. Lancet Oncol. 2004;5:480-488. [PMID: 15288237 DOI: 10.1016/S1470-2045(04)01527-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
136 Onaca N, Davis GL, Jennings LW, Goldstein RM, Klintmalm GB. Improved results of transplantation for hepatocellular carcinoma: A report from the international registry of hepatic tumors in liver transplantation. Liver Transpl 2009;15:574-80. [DOI: 10.1002/lt.21738] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
137 Kawamura Y, Ikeda K, Fukushima T, Hara T, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study: No-touch ablation procedure for hepatic tumors. Hepatol Res 2014;44:1234-40. [DOI: 10.1111/hepr.12240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
138 Sherman M. Screening for hepatocellular carcinoma. Hepatology Research 2007;37:S152-65. [DOI: 10.1111/j.1872-034x.2007.00180.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
139 Yamamoto J, Kosuge T, Saiura A, Sakamoto Y, Shimada K, Sano T, Takayama T, Sugawara Y, Yamaguchi T, Kokudo N, Makuuchi M. Effectiveness of Hepatic Resection for Early-stage Hepatocellular Carcinoma in Cirrhotic Patients: Subgroup Analysis according to Milan Criteria. Japanese Journal of Clinical Oncology 2007;37:287-95. [DOI: 10.1093/jjco/hym025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
140 Kamiyama T, Yokoo H, Kakisaka T, Orimo T, Wakayama K, Kamachi H, Tsuruga Y, Yamashita K, Shimamura T, Todo S, Taketomi A. Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy. Hepatol Res 2015;45:E21-31. [PMID: 25382703 DOI: 10.1111/hepr.12451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
141 Donckier V, Van Laethem JL, Van Gansbeke D, Ickx B, Lingier P, Closset J, El Nakadi I, Feron P, Boon N, Bourgeois N, Adler M, Gelin M. New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. J Surg Oncol 2003;84:36-44. [DOI: 10.1002/jso.10281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
142 Zhou YM, Wen YH, Kang XY, Qian HH, Yang JM, Yin ZF. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells. World J Gastroenterol 2008;14:2168-73. [PMID: 18407589 DOI: 10.3748/wjg.14.2168] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
143 Mela M, Mancuso A, Burroughs AK. Review article: hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther. 2003;17 Suppl 2:130-137. [PMID: 12786624 DOI: 10.1046/j.1365-2036.17.s2.16.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
144 Sutcliffe R, Maguire D, Portmann B, Rela M, Heaton N. Selection of patients with hepatocellular carcinoma for liver transplantation. British Journal of Surgery 2006;93:11-8. [DOI: 10.1002/bjs.5198] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
145 Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, Satani M, Yamada S, Okamura S, Hori M, Kakuma T, Torimura T, Sata M. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol 2014;21:1002-9. [PMID: 24254204 DOI: 10.1245/s10434-013-3376-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 9.5] [Reference Citation Analysis]
146 Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma. J Hepatol. 2003;39:888-895. [PMID: 14642602 DOI: 10.1016/j.jhep.2003.10.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
147 Sotiropoulos GC, Lang H, Nadalin S, Neuhäuser M, Molmenti EP, Baba HA, Paul A, Saner FH, Weber F, Hilgard P, Frilling A, Broelsch CE, Malagó M. Liver Transplantation for Hepatocellular Carcinoma: University Hospital Essen Experience and Metaanalysis of Prognostic Factors. Journal of the American College of Surgeons 2007;205:661-75. [DOI: 10.1016/j.jamcollsurg.2007.05.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
148 Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, Patch D, Davidson BR, Rolles K, Burroughs AK. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation. 2006;81:1532-1541. [PMID: 16770242 DOI: 10.1097/01.tp.0000209641.88912.15] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
149 Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, Colella G, Forti D. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transplant Int 2003;16:115-22. [DOI: 10.1111/j.1432-2277.2003.tb00272.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
150 Kotewall CN, Cheung TT. Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations. Transl Gastroenterol Hepatol 2018;3:75. [PMID: 30505962 DOI: 10.21037/tgh.2018.09.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
151 Plessier A, Codes L, Consigny Y, Sommacale D, Dondero F, Cortes A, Degos F, Brillet PY, Vilgrain V, Paradis V, Belghiti J, Durand F. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl. 2004;10:S86-S90. [PMID: 14762846 DOI: 10.1002/lt.20039] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
152 Wall WJ, Marotta PJ. Surgery and transplantation for hepatocellular cancer. Liver Transpl 2000;6:s16-22. [DOI: 10.1053/jlts.2000.19010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
153 Patt CH, Thuluvath PJ. Role of Liver Transplantation in the Management of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S205-10. [DOI: 10.1016/s1051-0443(07)61788-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
154 Gans JH, Lipman J, Golowa Y, Kinkhabwala M, Kaubisch A. Hepatic Cancers Overview: Surgical and Chemotherapeutic Options, How Do Y-90 Microspheres Fit in? Seminars in Nuclear Medicine 2019;49:170-81. [DOI: 10.1053/j.semnuclmed.2019.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Chen JS, Wang Q, Chen XL, Huang XH, Liang LJ, Lei J, Huang JQ, Li DM, Cheng ZX. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res. 2012;175:243-250. [PMID: 21601221 DOI: 10.1016/j.jss.2011.03.072] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
156 Theodoropoulos J, Brooks A. Inconsistency in the Management of Patients with Hepatocellular Carcinoma: The Need for a Strict Protocol. The American Surgeon 2011;77:207-14. [DOI: 10.1177/000313481107700223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Hoshida Y, Shiratori Y, Omata M. Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma: Interferon after resection of HCC. Liver 2002;22:479-85. [DOI: 10.1034/j.1600-0676.2002.01736.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
158 Fan ST, Cheung ST, Lo CM. Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma. J Gastroenterol Hepatol 2000;15 Suppl:E181-6. [PMID: 10921405 DOI: 10.1046/j.1440-1746.2000.02119.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
159 Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52 Suppl 3:iii1-iii8. [PMID: 12692148 DOI: 10.1136/gut.52.suppl_3.iii1] [Cited by in Crossref: 132] [Cited by in F6Publishing: 162] [Article Influence: 7.3] [Reference Citation Analysis]
160 Ng KK, Vauthey J, Pawlik TM, Lauwers GY, Regimbeau J, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT. Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional Database. Ann Surg Oncol 2005;12:364-73. [DOI: 10.1245/aso.2005.06.004] [Cited by in Crossref: 167] [Cited by in F6Publishing: 80] [Article Influence: 10.4] [Reference Citation Analysis]
161 Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000;19:189-99. [DOI: 10.1002/1098-2388(200009)19:2<189::aid-ssu10>3.0.co;2-u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
162 Durand F. Liver transplantation for hepatocellular carcinoma: Should we push the limits? Liver Transplantation 2003;9:697-9. [DOI: 10.1053/jlts.2003.50126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
163 Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. J Gastroenterol Hepatol. 2008;23:1739-1746. [PMID: 18713301 DOI: 10.1111/j.1440-1746.2008.05436.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
164 Bhoori S, Schiavo M, Russo A, Mazzaferro V. First-line treatment for hepatocellular carcinoma: resection or transplantation? Transplant Proc. 2007;39:2271-2273. [PMID: 17889160 DOI: 10.1016/j.transproceed.2007.06.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
165 Sarveazad A, Agah S, Babahajian A, Amini N, Bahardoust M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J Res Med Sci 2019;24:86. [PMID: 31741658 DOI: 10.4103/jrms.JRMS_1017_18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
166 Ismail H, Broniszczak D, Kaliciński P, Markiewicz-Kijewska M, Teisseyre J, Stefanowicz M, Szymczak M, Dembowska-Bagińska B, Kluge P, Perek D, Kościesza A, Dzik E, Lembas A, Teisserye M. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients? Pediatr Transplant 2009;13:682-92. [PMID: 19496985 DOI: 10.1111/j.1399-3046.2009.01062.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
167 Tranchart H, Chirica M, Sepulveda A, Massault P, Conti F, Scatton O, Soubrane O. Long-term Outcomes Following Aggressive Management of Recurrent Hepatocellular Carcinoma After Upfront Liver Resection. World J Surg 2012;36:2684-91. [DOI: 10.1007/s00268-012-1723-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]